Skip to content
2000
Volume 23, Issue 1
  • ISSN: 1570-162X
  • E-ISSN: 1873-4251

Abstract

Aims

In people living with human immune deficiency (PLHIV), the rates of human papillomavirus (HPV) infection, mixed types, and high-risk (HR) strains increase, while the virus clearance does not occur. Here, we report HPV genotyping in PLHIVs from Iran and the Middle East region for the first time.

Methods

HPV genotyping in referring individuals from different provinces to our laboratory was evaluated over 2023-2024. For this, the HPV types in specimens were detected through the INNO-LiPA HPV genotyping kit. Statistical analysis was conducted with a 95% confidence interval (95%CI) and < 0.05. Accordingly, 481 subjects from various provinces participated in this study.

Results

The rate of HPV infection was 45.7%, of which 14% were HIV-infected women referred from all provinces. The most prevalent types included 6, 51, and 18, but not 16 HR types. Mixed infections in dually infected women were significantly more than in HPV-infected ones. The HPV+/HIV+ subgroup had the lowest median age. The prevalence of HPV types and mixed infection in PLHIVs was congruent with the previous reports, except for the low rate of type 16 infection, perhaps due to the healthy nature of our subjects. Only HIV+/HPV+ cases' age was similar to the previous reports, perhaps because of sample collection and study designs. Among all factors, age and gender affected the HPV type distribution notably.

Conclusion

The current study corroborated the results of many prior reports, demonstrating the considerable impact of HIV status on HPV distribution. The authors recommend implementing a national HPV vaccination and more comprehensive reports of HPV genotyping in PLHIVs.

Loading

Article metrics loading...

/content/journals/chr/10.2174/011570162X352564250112035117
2025-01-22
2025-08-27
Loading full text...

Full text loading...

References

  1. DreyerG. Clinical implications of the interaction between HPV and HIV infections.Best Pract. Res. Clin. Obstet. Gynaecol.2018479510610.1016/j.bpobgyn.2017.08.01128958633
    [Google Scholar]
  2. EgawaN. DoorbarJ. The low-risk papillomaviruses.Virus Res.201723111912710.1016/j.virusres.2016.12.01728040475
    [Google Scholar]
  3. BogaleA.L. BelayN.B. MedhinG. AliJ.H. Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: Systematic review and meta-analysis.Virol. J.202017117910.1186/s12985‑020‑01448‑133198743
    [Google Scholar]
  4. FarahmandZ. SoleimanjahiH. GarshasbiM. HasanzadehM. ZafariE. Distribution of the most common types of HPV in Iranian women with and without cervical cancer.Women Health2021611738210.1080/03630242.2020.182249032957835
    [Google Scholar]
  5. SabetF. MosavatA. GhezeldashtA.S. BasharkhahS. ShamsianS.A.A. AbbasniaS. ShamsianK. RezaeeS.A. Prevalence, genotypes and phylogenetic analysis of human papillomaviruses (HPV) in northeast Iran.Int. J. Infect. Dis.202110348048810.1016/j.ijid.2020.12.01533310023
    [Google Scholar]
  6. ZandiK. EghbaliS.S. HamkarR. AhmadiS. ramedaniE. DeilamiI. NejadH.A. FarshadpourF. RastianZ. Prevalence of various human papillomavirus (hpv) genotypes among women who subjected to routine pap smear test in bushehr city (south west of iran)2008-2009.Virol. J.2010716510.1186/1743‑422X‑7‑6520302680
    [Google Scholar]
  7. MehranS.M.M. GhanaeiM.M. MojtehadiA. The prevalence of human papilloma virus (HPV) in women using liquid base pap smear in rasht, northern of iran.J. Clin. Diagn. Res.201597IC01IC0210.7860/JCDR/2015/8206.613926393145
    [Google Scholar]
  8. ChewK.W. BhattacharyaD. Virologic and immunologic aspects of HIV–hepatitis C virus coinfection.AIDS201630162395240410.1097/QAD.000000000000120327427873
    [Google Scholar]
  9. PinatoD.J. PriaD.A. SharmaR. BowerM. Hepatocellular carcinoma.AIDS201731560361110.1097/QAD.000000000000142228121711
    [Google Scholar]
  10. WangC.C.J. PalefskyJ.M. HPV-associated anal cancer in the hiv/aids patient.Cancer Treat. Res.201917718320910.1007/978‑3‑030‑03502‑0_730523625
    [Google Scholar]
  11. GuidryJ.T. ScottR.S. The interaction between human papillomavirus and other viruses.Virus Res.201723113914710.1016/j.virusres.2016.11.00227826043
    [Google Scholar]
  12. NgouJ. GilhamC. OmarT. LompoG.O. DoutreS. MichelowP. KellyH. DidelotM.N. ChikandiwaA. SawadogoB. MoretlweO.S. MedaN. CostesV. MayaudP. SegondyM. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.J. Acquir. Immune Defic. Syndr.201568216216810.1097/QAI.000000000000042825394189
    [Google Scholar]
  13. ZarnaqK.R. MosaddeghradA.M. NadrianH. KabiriN. RavaghiH. Comprehensive analysis of the HIV/AIDS policy-making process in Iran.Health Res. Policy Syst.20191716910.1186/s12961‑019‑0466‑631324185
    [Google Scholar]
  14. MoghoofeiM. NajafipourS. MostafaeiS. TavakoliA. SalimB.F. GhorbaniS. JavanmardD. GhaffariH. MonavariS.H. MicroRNAs Profiling in HIV, HCV, and HIV/HCV Co-Infected Patients.Curr. HIV Res.2021191273410.2174/18734251MTA5ANzcu532900348
    [Google Scholar]
  15. HashianiA.A. SadeghiF. AyubiE. RezaeianS. MoradiY. MansoriK. GholamalieiB. MohammadbeigiA. KhazaeiS. Prevalence of HIV, hepatitis B and C virus co-infections among iranian high-risk groups: A systematic review and meta-analysis.Malays. J. Med. Sci.2019263374810.21315/mjms2019.26.3.331303849
    [Google Scholar]
  16. ShahriariradR. ErfaniA. RastegarianM. ZeighamiA. ArefkhahN. GhorbaniF. SarvariJ. SarkariB. Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran.Virol. J.202017110910.1186/s12985‑020‑01384‑032680534
    [Google Scholar]
  17. MbulawaZ.Z.A. CoetzeeD. WilliamsonA.L. Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status.BMC Infect. Dis.201515145910.1186/s12879‑015‑1181‑826502723
    [Google Scholar]
  18. KeshehM.M. KeyvaniH. The prevalence of hpv genotypes in iranian population: An update.Iran. J. Pathol.201914319720510.30699/IJP.2019.90356.186131582996
    [Google Scholar]
  19. BehzadiM.A. DavarpanahM.A. NamayandehM. PourabbasB. AllahyariS. ZiyaeyanM. Molecular diagnosis of genital tract infections among HIV-positive women in Iran.Iran. J. Microbiol.201810423324130483375
    [Google Scholar]
  20. LinC. FranceschiS. CliffordG.M. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: A systematic review and meta-analysis.Lancet Infect. Dis.201818219820610.1016/S1473‑3099(17)30653‑929158102
    [Google Scholar]
  21. NdizeyeZ. BroeckD. LebeloR.L. BogersJ. BenoyI. GeertruydenV.J.P. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.PLoS One2019146e020930310.1371/journal.pone.020930331237894
    [Google Scholar]
  22. SossoS.M. TchouaketM.C.T. FokamJ. SimoR.K. SemengueE.N.J. SandoZ. TorimiroJ. TigaA. LobeE.E. AmbadaG. NangeA. NkaA.D. ChenwiC. AbbaA. Ka’eA.C. FainguemN. ZamM.K.N. YagaiB. BillongS.C. ColizziV. NdjoloA. Human papillomavirus positivity and cervical lesions in relation to HIV infection: A comparative assessment in the Cameroonian female population.J. Public Health Africa20231410710.4081/jphia.2023.233437942060
    [Google Scholar]
  23. KellyH.A. NgouJ. ChikandiwaA. SawadogoB. GilhamC. OmarT. LompoO. DoutreS. MedaN. WeissH.A. MoretlweD.S. SegondyM. MayaudP. HARP Study Group Associations of human papillomavirus (HPV) genotypes with high-grade cervical neoplasia (cin2+) in a cohort of women living with HIV in Burkina Faso and South Africa.PLoS One2017123e017411710.1371/journal.pone.017411728333966
    [Google Scholar]
  24. PakdelF. FarhadiA. PakdelT. TadbirA.A. AlaviP. BehbahaniB.A. AshrafM.J. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16INK4a and NF-κB expression in head and neck squamous cell carcinomas in Southwestern Iran.Braz. J. Microbiol.202152119520610.1007/s42770‑020‑00391‑133169334
    [Google Scholar]
  25. MenonS. WusimanA. BoilyM.C. KariisaM. MabeyaH. LuchtersS. ForlandF. RossiR. CallensS. Broeckv.D. Epidemiology of hpv genotypes among HIV positive women in Kenya: A systematic review and meta-analysis.PLoS One20161110e016396510.1371/journal.pone.016396527764092
    [Google Scholar]
  26. KaraniL.W. MusyokiS. OrinaR. NyamacheA.K. WandabwaK.C. NyagakaB. Human papillomavirus genotype profiles and cytological grades interlinkages in coinfection with HIV.Pan Afr. Med. J.2020356710.11604/pamj.2020.35.67.2153932537071
    [Google Scholar]
  27. Silvad.B.E.B. SantosV.S. SantosI.E.R. AraújoE.D. AlvesM.V. SilvaL.A.S. de Aragão BatistaM.V. Lemosd.L.M.D. Prevalence and genotype distribution of human papillomavirus in women living with HIV/AIDS in an area of Northeast Brazil.J. Med. Virol.202092123279328710.1002/jmv.2593532330294
    [Google Scholar]
  28. MbathaJ.N. TaylorM. KleppaE. LilleboK. ArachchigeG.H.N. SinghD. KjetlandE.F. BaayM.F.D. KwitshanaM.Z.L. High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: Implications for vaccination.Infect. Dis.201749860160810.1080/23744235.2017.131251328403727
    [Google Scholar]
  29. OmireA. BudambulaN.L.M. KirumbiL. LangatH. KerosiD. OchiengW. LwembeR. Cervical dysplasia, infection, and phylogeny of human papillomavirus in hiv-infected and hiv-uninfected women at a reproductive health clinic in nairobi, Kenya.BioMed Res. Int.2020202011010.1155/2020/494560832685493
    [Google Scholar]
  30. BrischiliariR.S.C. GimenesF. Abreud.A.L.P. IrieM.M.T. SouzaR.P. SantanaR.G. GravenaA.A.F. de B CarvalhoM.D. ConsolaroM.E.L. PellosoS.M. Risk factors for cervical HPV infection and genotypes distribution in HIV-infected South Brazilian women.Infect. Agent. Cancer201491610.1186/1750‑9378‑9‑624517499
    [Google Scholar]
  31. VaziriS.M. SadeghiF. SalimB.F. YounesiS. AlinaghiS. MonavariS.H. KeyvaniH. The prevalence and genotype distribution of human papillomavirus in the genital tract of males in Iran.Jundishapur J. Microbiol.2015812e2191210.5812/jjm.2191226862386
    [Google Scholar]
  32. RibeiroM.G.M. MarcolinoL.D. RamosB.R.A. TrentoC.L. AraujoK.C.G.M. SilvaJ.R.S. JainS. GurgelR.Q. SilvaM.G. DolabellaS.S. Elevated prevalence of high-risk HPV in healthy oral mucosa of users and nonusers of drugs in Northeastern Brazil.Braz. Oral Res.201933e03110.1590/1807‑3107bor‑2019.vol33.003130994708
    [Google Scholar]
  33. BettampadiD. VillaL.L. PonceE.L. SalmeronJ. SirakB.A. AbrahamsenM. RathwellJ.A. ReichR.R. GiulianoA.R. Oral human papillomavirus prevalence and type distribution by country (Brazil, Mexico and the United States) and age among HPV infection in men study participants.Int. J. Cancer2020146113026303310.1002/ijc.3271331583681
    [Google Scholar]
  34. BitarafanF. HekmatM.R. KhodaeianM. RazmaraE. AshrafganjoeiT. GilaniM.M. MohitM. AminimoghaddamS. CheraghiF. KhalesiR. RajabzadehP. SarmadiS. GarshasbiM. Prevalence and genotype distribution of human papillomavirus infection among 12 076 Iranian women.Int. J. Infect. Dis.202111129530210.1016/j.ijid.2021.07.07134343706
    [Google Scholar]
  35. OuhY.T. MinK.J. ChoH.W. KiM. OhJ.K. ShinS.Y. HongJ.H. LeeJ.K. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016.J. Gynecol. Oncol.2018291e1410.3802/jgo.2018.29.e1429185272
    [Google Scholar]
  36. DavarmaneshM. JazayeriS.M. DezfulianM. GharaviM.J. High risk genotype distribution of human papillomavirus (HPV) according to age groups in Iranian asymptomatic men.Infect. Agent. Cancer20201512910.1186/s13027‑020‑00296‑632411292
    [Google Scholar]
  37. ZhangJ. ChengK. WangZ. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: A meta-analysis.Arch. Gynecol. Obstet.202030261329133710.1007/s00404‑020‑05787‑w32914222
    [Google Scholar]
/content/journals/chr/10.2174/011570162X352564250112035117
Loading
/content/journals/chr/10.2174/011570162X352564250112035117
Loading

Data & Media loading...

Supplements

S1: Table of demographic data and HPV genotyping distribution in HIV-infected and uninfected groups. S2: Table of LR, HR, and HR-LR HPV types of mixed infections and their frequency in HIV-positive and negative groups.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test